World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
47670
World Ranking
7553
National Ranking
739

Sarah E Pinder publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sarah E Pinder sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 658 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sarah E Pinder D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sarah E Pinder sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sarah E Pinder is affiliated with King's College London in the United Kingdom and has an extensive publication record focused primarily on cancer research and related biomedical fields.

Their research spans several main fields of study including Medicine and Biochemistry, Genetics and Molecular Biology. Within these broader disciplines, they have concentrated on subfields such as Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, and Molecular Biology.

The main topics covered in their work include:

  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Global Cancer Incidence and Screening
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • AI in cancer detection
  • Cancer Immunotherapy and Biomarkers

Among their recent academic papers are:

  • Spatial genomics maps the structure, nature and evolution of cancer clones, 2022, Nature
  • Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer, 2021, Cancer Research
  • Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer, 2022, Nature Genetics
  • Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer, 2021, Modern Pathology
  • Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression, 2021, Science Advances

They have frequently published in venues including Cancer Research, European Journal of Surgical Oncology, British Journal of Cancer, Clinical Cancer Research, and bioRxiv (Cold Spring Harbor Laboratory).

Their collaboration network includes frequent co-authors such as Alastair M. Thompson, Abeer M. Shaaban, Elinor J. Sawyer, Hilary Stobart, and Anita Grigoriadis.

Best Publications

  • The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

    Christina Curtis;Christina Curtis;Sohrab P Shah;Suet-Feung Chin;Gulisa Turashvili

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Pathological prognostic factors in breast cancer.

    Christopher W. Elston;Ian O. Ellis;Sarah E. Pinder

  • The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes

    Bernard Pereira;Suet Feung Chin;Oscar M. Rueda;Hans Kristian Moen Vollan

  • Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial

    Andrew Tutt;Andrew Tutt;Holly Tovey;Maggie Chon U Cheang;Sarah Kernaghan

  • High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

    Dalia M. Abd El-Rehim;Graham Ball;Sarah E. Pinder;Emad Rakha

  • Expression of luminal and basal cytokeratins in human breast carcinoma

    Dalia M Abd El-Rehim;Sarah E Pinder;Claire E Paish;J Bell

  • Lancet Oncol 10

    Jack Cuzick;Ivana Sestak;Sarah E. Pinder;Ian O. Ellis

  • Terahertz pulsed spectroscopy of freshly excised human breast cancer

    Philip C. Ashworth;Emma Pickwell-MacPherson;Elena Provenzano;Sarah E. Pinder

  • An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

    Andrew E Teschendorff;Ahmad Miremadi;Sarah E Pinder;Ian O Ellis

  • Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

    Jack Cuzick;Ivana Sestak;Sarah E Pinder;Ian O Ellis

  • Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients.

    Robin Stuart-Harris;C Caldas;S Pinder;P Pharoah

  • Histological grading of breast carcinomas: A study of interobserver agreement

    P Robbins;P Robbins;S Pinder;S Pinder;N de Klerk;N de Klerk;H Dawkins;H Dawkins

  • Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Y S Ju;L B Alexandrov;M Gerstung;I Martincorena

  • High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.

    Suet F Chin;Andrew E Teschendorff;John C Marioni;Yanzhong Wang

  • Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer

    Julia Margaret Wendy Gee;J. F. Robertson;E. Gutteridge;I. O. Ellis

  • Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up

    S.E. Pinder;I.O. Ellis;M. Galea;S. O'rouke

  • Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

    Thomas C Putti;Dalia M Abd El-Rehim;Emad A Rakha;Claire E Paish

  • Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.

    Peter T Simpson;Theo Gale;Jorge S Reis-Filho;Chris Jones

  • Addressing overtreatment of screen detected DCIS; the LORIS trial

    Adele Francis;Jeremy Thomas;Lesley Fallowfield;Matthew Wallis

Frequent Co-Authors

Ian O. Ellis
Ian O. Ellis University of Nottingham
Andrew Evans
Andrew Evans University of Dundee
C.W. Elston
C.W. Elston University of Nottingham
Roger W. Blamey
Roger W. Blamey Nottingham City Hospital
John M. S. Bartlett
John M. S. Bartlett University of Toronto
Fiona J. Gilbert
Fiona J. Gilbert University of Cambridge
Luke Vale
Luke Vale Newcastle University
Christophe Fraser
Christophe Fraser University of Oxford
John F.R. Robertson
John F.R. Robertson University of Nottingham
Andrew Tutt
Andrew Tutt Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but seeking alternative or complementary career routes to studying Medicine in the USA, online degrees offer flexibility and a range of professional opportunities. One relevant choice is online nutrition degree programs, which can lead to rewarding roles in clinical nutrition, wellness coaching, and public health education.

For those aiming at leadership or administrative roles in healthcare, pursuing one of the top cahme-accredited mha programs can pave the way toward management positions in hospitals, clinics, or health systems.

Registered Nurses looking to advance can consider rn to bsn no clinical hours programs, designed for working RNs who want to complete their Bachelor of Science in Nursing online without additional in-person requirements.

For those at the pinnacle of nursing, there are dnp programs online that offer advanced practice and leadership training, with flexible formats ideal for busy professionals.

Each of these online pathways provides convenient, accredited options for building a dynamic healthcare career—without the need to commit to a traditional medical degree.

Best Scientists Citing Sarah E Pinder

Trending Scientists